Main >> Labarai >> FDA ta amince da tsarin farko na Proventil HFA

FDA ta amince da tsarin farko na Proventil HFA

FDA ta amince da tsarin farko na Proventil HFALabarai

Hukumar Abinci da Magunguna ta Amurka (FDA) ta ba da izini ga Cipla Limited don ƙera nau'ikan fasalin farko na Proventil HFA ( albuterol sulfate ) inhaler mai karfin awo, 90 mcg / inhalation.





Abin farin ciki, kamfanin kera ProAir, ya fito da tsarin izini na ProAir a watan Afrilu 2019, an kawo shi kuma an rarraba ta ɗayan Endo International’s kamfanonin aiki, Par Pharmaceuticals. Wannan sabon juzu'in shine kwafin farko na asali, wanda ba Merck ya samar dashi ba. Ma'ana, yana ƙara sabon gasa a kasuwa, wanda yakamata ya taimaka rage farashin.



Menene Proventil generic?

Wannan nau'in inhaler na musamman, wanda wani lokaci ake kira da inhaler mai ceto, an yi niyyar amfani dashi don hana ko magance cututtukan fuka a cikin mutanen da shekarunsu suka kai 4 zuwa sama waɗanda ke da cutar da ke hana iska iska. Hakanan za'a iya amfani dashi don rigakafin motsa jiki wanda ya haifar da bronchospasm. Kimanin mutane miliyan 25 , ciki har da kusan yara miliyan 7, a Amurka suna da asma, a cewar Cibiyar Kula da Rigakafin Cututtuka (CDC).

ProAir HFA (albuterol inhaler) da Proventil HFA (albuterol inhaler) suna daga cikin nau'ikan da ake amfani da su na albuterol sulfate na masu gajeren aiki na bronchodilators a kasuwa. Sauran sun hada da Ventolin HFA (albuterol inhaler) da AccuNeb (albuterol nebulizer bayani).

Menene sakamakon tasirin Proventil HFA generic?

Abubuwan da suka fi dacewa ga irin wannan magani sun haɗa da rhinitis, tashin zuciya, amai, saurin bugun zuciya, rawar jiki, firgita, da kamuwa da cutar numfashi ta sama, a cewar FDA.



Fa'idodin Proventil HFA na asali

Wannan yarjejjeniyar ta zo yan makonni kadan bayanda FDA ta amince da wani sinadarin inno na albuterol. FDA ta ba da izini ga Kamfanin Magunguna na Perrigo don fara ƙera ƙirar farko ta farko Harshen ProAir (albuterol sulfate) inhalation aerosol a ƙarshen Fabrairu .

Gabaɗaya magana, sakin wani nau'in nau'ikan albuterol labari ne mai daɗi ga mutanen da ke buƙatar irin wannan magani, a cewar masanin ilimin alerji J. Allen Meadows, MD, shugaban kwalejin Amurka na Allergy, Asthma and Immunology (ACAAI).

Yana kara wadatar kayayyaki kuma yana rage kudin wasu, cikin kankanin lokaci, in ji Dokta Meadows.



Lokacin karuwar bukata

A cewar kwamishinan FDA Stephen M. Hahn, MD, tuni an sami karuwar buƙata ga irin wannan samfurin.

Hukumar ta FDA ta fahimci karuwar bukatar kayayyakin albuterol yayin bazuwar cutar kwayar cutar coronavirus, in ji Dokta Hahn a cikin sanarwa sanar da amincewa a ranar 8 ga Afrilu. Mun kasance cikin himma sosai don sauƙaƙe hanyoyin samun kayayyakin likitanci don taimakawa magance mahimman buƙatun jama'ar Amurka.

Makonni da yawa da suka gabata, ACAAI ta fitar da sanarwa da ke nuna karancin inhalers na albuterol a wasu yankuna na kasar, saboda wani bangare na karin amfani da inhalers ga marasa lafiya a asibiti tare da COVID-19 cututtuka . Wasu asibitocin sun taƙaita amfani da magungunan nebul saboda fargabar cewa za su iya yaɗa cutar ta iska.



Amma ACAAI ta tunatar da mutane cewa kar su firgita kuma kada su damu da batun tarawa, saboda kwaya daya na albuterol ya kamata ya kwashe watanni. A cewar Dokta Meadows, mai shaƙar ceto ɗaya zai ɗauki watanni shida zuwa 18. Idan kana amfani da inhaler na cetonka da wuri, mai yiwuwa ba haka bane sarrafa asma da kyau isa. A wannan yanayin, zaku iya yin magana da likitan ku game da daidaitawa ko canza magungunan rigakafin da kuke sha.

Koyaya, wasu mutane na iya damuwa game da ƙarancin inhalers na ceton albuterol, don haka labarin wani samfurin albuterol da ya faɗa kasuwa na iya zama mai kwantar musu da hankali, in ji Dokta Meadows



Ya kamata mu sami yalwa-kada ku damu, in ji shi.

Yaushe za a sami wadataccen tsari?

A halin yanzu, ba a san ainihin lokacin da sabon jigon zai shiga kasuwar Amurka ba. Wata sanarwa da Cipra ta fitar a ranar 9 ga Afrilu ya ce, Muna shirin jigilar kayayyaki ta wata hanya wacce ba za ta yiwu ba. Har ila yau, muna tabbatar da cewa mun yi iya ƙoƙarinmu ta hanyar ba da gudummawar samfurin a wannan lokacin da ake buƙata.